Spots Global Cancer Trial Database for Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies
Official Title: A Phase 1a/b Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Subjects With Solid Malignancies
Study ID: NCT05006794
Conditions
Study Description
Brief Summary: This is a Phase I open-label, multi-center study of GS-9716 tested either as monotherapy or in combination with other anti-cancer agents in patients with advanced solid malignancies. Primary objectives are to define the maximum tolerated dose (MTD) or maximum administered dose of GS-9716, and characterize the safety and tolerability of GS-9716 as monotherapy and in combination with anti-cancer therapies.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora, Colorado, United States
Moffitt Cancer Center, Tampa, Florida, United States
START Midwest, Grand Rapids, Michigan, United States
Montefiore Medial Center - Montefiore Medical Park, Bronx, New York, United States
Oregon Health Oregon Health & Sciences University-Knight Cancer Institute, Portland, Oregon, United States
Sarah Cannon Research Institute, Nashville, Tennessee, United States
START San Antonio, San Antonio, Texas, United States
START Mountain Region, West Valley City, Utah, United States
Rambam Health Care Campus, Haifa, , Israel
Hadassah Medical Center- Ein Kerem, Jerusalem, , Israel
Tel-Aviv Sourasky Medical Center, Tel Aviv, , Israel
Contact Details
Name: Gilead Study Director
Affiliation: Gilead Sciences
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
